But for regular users who arent subject to tabloid scrutiny, Ozempic is nothing to be ashamed about
Obes Surg 35(3):11271134 Esparham A et al (2024) Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: a systematic review and meta-analysis
Additionally, this agonist ameliorated diabetic nephropathy-related diseases in this study
Another trial evaluating the effects of semaglutide oral on cardiovascular outcomes in over 7,400 patients found that the treatment arm experienced a significant reduction in major adverse cardiovascular events (MACE) compared to the placebo arm
Heres a quick breakdown of how they work: Comparing Effectiveness for Weight Loss Both semaglutide and tirzepatide are effective for weight loss, but tirzepatide has shown stronger results in clinical studies
Our approach has made a real difference, enabling us to now expand options while continuing to make progress on affordability
